Cargando…
Notch Signaling in Breast Cancer: A Role in Drug Resistance
Breast cancer is a heterogeneous disease that can be subdivided into unique molecular subtypes based on protein expression of the Estrogen Receptor, Progesterone Receptor, and/or the Human Epidermal Growth Factor Receptor 2. Therapeutic approaches are designed to inhibit these overexpressed receptor...
Autores principales: | BeLow, McKenna, Osipo, Clodia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601482/ https://www.ncbi.nlm.nih.gov/pubmed/33003540 http://dx.doi.org/10.3390/cells9102204 |
Ejemplares similares
-
Trastuzumab Resistance: Role for Notch Signaling
por: Mehta, Kinnari, et al.
Publicado: (2009) -
Gamma secretase inhibitors of Notch signaling
por: Olsauskas-Kuprys, Roma, et al.
Publicado: (2013) -
Notch-EGFR/HER2 Bidirectional Crosstalk in Breast Cancer
por: Baker, Andrew T., et al.
Publicado: (2014) -
NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications
por: Clementz, Anthony G, et al.
Publicado: (2011) -
Targeting Breast Cancer Stem Cells Using Naturally Occurring Phytoestrogens
por: Nguyen, Mai, et al.
Publicado: (2022)